1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of VASN mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1598149 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of VASN mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of VASN mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of VASN mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1605593 6480464 Estradiol promotes the reaction [ESR2 protein affects the expression of VASN mRNA] CTD PMID:20404318 17beta-estradiol multiple interactions ISO RGD:1598149 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of VASN mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:1605593 6480464 Estradiol results in increased expression of VASN mRNA CTD PMID:23019147 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1605593 6480464 Tetrachlorodibenzodioxin results in increased expression of VASN mRNA CTD PMID:21802500 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VASN mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VASN mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1598149 6480464 Tetrachlorodibenzodioxin results in decreased expression of VASN mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1598149 6480464 Tetrachlorodibenzodioxin affects the expression of VASN mRNA CTD PMID:22298810 2-hydroxypropanoic acid decreases expression ISO RGD:1605593 6480464 Lactic Acid results in decreased expression of VASN mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1605593 6480464 beta-methylcholine affects the expression of VASN mRNA CTD PMID:21179406 4,4'-sulfonyldiphenol decreases expression ISO RGD:1605593 6480464 bis4-hydroxyphenylsulfone results in decreased expression of VASN mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis4-hydroxyphenylsulfone results in increased expression of VASN mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of VASN mRNA CTD PMID:28973697 all-trans-retinoic acid increases expression ISO RGD:1605593 6480464 Tretinoin results in increased expression of VASN mRNA CTD PMID:23724009 all-trans-retinoic acid multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of VASN mRNA CTD PMID:30951980 benzo[a]pyrene multiple interactions EXP 6480464 Benzoapyrene promotes the reaction [AHR protein binds to VASN promoter] CTD PMID:19654925 benzo[a]pyrene affects methylation ISO RGD:1605593 6480464 Benzoapyrene affects the methylation of VASN promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1605593 6480464 Benzoapyrene results in increased methylation of VASN 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1605593 6480464 Benzoapyrene results in increased expression of VASN mRNA CTD PMID:20064835 bis(2-chloroethyl) sulfide increases expression ISO RGD:1605593 6480464 Mustard Gas results in increased expression of VASN mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1605593 6480464 Diethylhexyl Phthalate results in increased expression of VASN mRNA CTD PMID:31163220 bisphenol A increases expression ISO RGD:1605593 6480464 bisphenol A results in increased expression of VASN mRNA CTD PMID:23019147 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VASN mRNA CTD PMID:30951980 bisphenol A increases expression ISO RGD:1598149 6480464 bisphenol A results in increased expression of VASN mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1598149 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of VASN mRNA CTD PMID:26496021 bisphenol F multiple interactions EXP 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of VASN mRNA CTD PMID:30951980 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of VASN mRNA CTD PMID:30951980 cadmium dichloride increases methylation ISO RGD:1598149 6480464 Cadmium Chloride results in increased methylation of VASN promoter CTD PMID:22457795 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of VASN mRNA CTD PMID:25620056 chloropicrin increases expression ISO RGD:1605593 6480464 chloropicrin results in increased expression of VASN mRNA CTD PMID:26352163 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of VASN mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of VASN mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1605593 6480464 Cisplatin results in increased expression of VASN mRNA CTD PMID:19561079 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of VASN mRNA CTD PMID:23811191 cobalt atom multiple interactions ISO RGD:1605593 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of VASN mRNA CTD PMID:23052192 copper(II) sulfate decreases expression ISO RGD:1605593 6480464 Copper Sulfate results in decreased expression of VASN mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1605593 6480464 Cyclosporine results in decreased expression of VASN mRNA CTD PMID:25562108 cytarabine decreases expression ISO RGD:1605593 6480464 Cytarabine results in decreased expression of VASN mRNA CTD PMID:21198554 diazinon increases methylation ISO RGD:1605593 6480464 Diazinon results in increased methylation of VASN gene CTD PMID:22964155 dibenz[a,h]anthracene decreases expression EXP 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate increases expression ISO RGD:1598149 6480464 Dibutyl Phthalate results in increased expression of VASN mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of VASN mRNA CTD PMID:17361019 , PMID:21266533 dinophysistoxin 1 increases expression ISO RGD:1605593 6480464 dinophysistoxin 1 results in increased expression of VASN mRNA CTD PMID:21853993 , PMID:28939011 endosulfan decreases expression ISO RGD:1598149 6480464 Endosulfan results in decreased expression of VASN mRNA CTD PMID:29391264 fenamidone increases expression EXP 6480464 fenamidone results in increased expression of VASN mRNA CTD PMID:27029645 genistein increases expression ISO RGD:1605593 6480464 Genistein results in increased expression of VASN mRNA CTD PMID:23019147 hydroquinone increases expression ISO RGD:1605593 6480464 hydroquinone results in increased expression of VASN mRNA CTD PMID:31256213 isobutanol multiple interactions ISO RGD:1605593 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of VASN mRNA CTD PMID:29432896 lead(0) affects expression ISO RGD:1605593 6480464 Lead affects the expression of VASN mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1605593 6480464 Lead affects the expression of VASN mRNA CTD PMID:28903495 menadione affects expression ISO RGD:1605593 6480464 Vitamin K 3 affects the expression of VASN mRNA CTD PMID:20044591 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of VASN mRNA CTD PMID:18502557 oxaliplatin multiple interactions ISO RGD:1598149 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of VASN mRNA CTD PMID:25729387 ozone decreases expression EXP 6480464 Ozone results in decreased expression of VASN mRNA CTD PMID:31626304 paracetamol increases expression ISO RGD:1605593 6480464 Acetaminophen results in increased expression of VASN mRNA CTD PMID:21420995 , PMID:29067470 perfluorooctanoic acid decreases expression ISO RGD:1605593 6480464 perfluorooctanoic acid results in decreased expression of VASN protein CTD PMID:26879310 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of VASN mRNA CTD PMID:23091169 pioglitazone multiple interactions ISO RGD:1605593 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA, pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA] CTD PMID:20847119 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of VASN mRNA CTD PMID:18445702 potassium chromate decreases expression ISO RGD:1605593 6480464 potassium chromateVI results in decreased expression of VASN mRNA CTD PMID:22714537 potassium dichromate increases expression ISO RGD:1605593 6480464 Potassium Dichromate results in increased expression of VASN protein CTD PMID:23718831 quercetin decreases expression ISO RGD:1605593 6480464 Quercetin results in decreased expression of VASN mRNA, Quercetin results in decreased expression of VASN protein CTD PMID:19207037 , PMID:21632981 rac-lactic acid decreases expression ISO RGD:1605593 6480464 Lactic Acid results in decreased expression of VASN mRNA CTD PMID:30851411 silicon dioxide decreases expression ISO RGD:1605593 6480464 Silicon Dioxide analog results in decreased expression of VASN mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of VASN mRNA CTD PMID:23221170 sirolimus decreases expression ISO RGD:1598149 6480464 Sirolimus results in decreased expression of VASN mRNA CTD PMID:17028423 sunitinib decreases expression ISO RGD:1605593 6480464 Sunitinib results in decreased expression of VASN mRNA CTD PMID:31533062 tacrolimus hydrate decreases expression ISO RGD:1598149 6480464 Tacrolimus results in decreased expression of VASN mRNA CTD PMID:17028423 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of VASN mRNA CTD PMID:25123088 tert-butyl hydroperoxide multiple interactions ISO RGD:1605593 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression ISO RGD:1605593 6480464 tert-Butylhydroperoxide results in increased expression of VASN mRNA CTD PMID:20847119 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of VASN mRNA CTD PMID:17484886 titanium dioxide decreases expression ISO RGD:1598149 6480464 titanium dioxide results in decreased expression of VASN mRNA CTD PMID:30012374 topotecan multiple interactions ISO RGD:1598149 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of VASN mRNA CTD PMID:25729387 triclosan increases expression ISO RGD:1605593 6480464 Triclosan results in increased expression of VASN mRNA CTD PMID:30510588 troglitazone multiple interactions ISO RGD:1605593 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA, troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA] CTD PMID:20847119 Tungsten carbide multiple interactions ISO RGD:1605593 6480464 [tungsten carbide co-treated with Cobalt] results in increased expression of VASN mRNA CTD PMID:23052192 urethane increases expression ISO RGD:1605593 6480464 Urethane results in increased expression of VASN mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1605593 6480464 Valproic Acid results in decreased expression of VASN mRNA CTD PMID:29154799
